Ads
related to: Treatment Macular Degeneration- Sign Up For More Updates
Register Now to Receive More Info
On Genetic Testing, Today
- About IRD
Learn More About Gene Variants
Find Out More About IRD
- Genetic Testing Benefits
View Potential Testing Benefits
Uncover New Insights & More Answers
- Community Resources
Learn More About the Available
Online Resources. Get Info Now.
- Sign Up For More Updates
NGM Biopharmaceuticals: Eye Disorder Data Due 2nd Half Of 2022 (NASDAQ:NGM)
Seeking Alpha· 6 days agoThis will be the release of results from the phase 2 CATALINA study using NGM621 for the treatment...
LumiThera Presents US LIGHTSITE III Trial Data Showing Improvement in Vision in Intermediate Dry...
WFMZ Eastern Pennsylvania and Western New Jersey· 5 days agoSEATTLE, June 22, 2022 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company...
Kinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related ...
Morningstar· 3 days agoKinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related Macular Degeneration and potential advantages of KIN001 ...
Morphology of en face Haller vessel and macular neovascularization at baseline and 3 months as...
Nature· 2 days agoThe inclusion criteria were age 50 years or older, treatment-naïve nAMD confirmed by multimodal retinal imaging (fluorescein angiography, indocyanine green angiography, and ...
Cost of ranibizumab port delivery system for treating nAMD examined
Medical Xpress· 3 days agoFor patients with neovascular age-related macular degeneration (nAMD), ranibizumab with a port...
Adverum Biotechnologies Obtains EMA’s Priority Medicines Status For Chronic Eye Disorder Candidate -...
Benzinga· 2 days agoThe European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to Adverum Biotechnologies’ ADVM lead drug ADVM-022 for the treatment of wet age-related ...
Apellis (APLS) Expands Deal for Targeted Complement Therapies
Zacks via Yahoo Finance· 3 days agoApellis (APLS) expands its current research and development deal with privately held company,...
EyePoint Pharmaceuticals Announces Election of Tony Adamis, M.D. to Board of Directors
Morningstar· 3 days agoDr. Adamis is a highly accomplished ophthalmology executive with more than 30 years of research and development experience in the biopharmaceutical industry. “Dr. Adamis is a pioneer in the ...
Vision changes after 40? Here's what you need to know
The Port Lavaca Wave· 2 days agoThe American Academy of Ophthalmology (AAO) suggests everyone see an ophthalmologist for a baseline eye disease screening at age 40, even if there are no apparent problems with their vision.
Foundation Fighting Blindness Announces Leadership Changes
WCTV Tallahassee· 6 days agoThe Foundation Fighting Blindness, the world's leading organization committed to finding treatments and cures for blinding retinal diseases, announced today the promotions ...
Ads
related to: Treatment Macular Degenerationvisionalive.net has been visited by 10K+ users in the past month
